Ann: MedAdvisor $9.5m Investment from EBOS, page-7

  1. 1,864 Posts.
    lightbulb Created with Sketch. 80
    To formalise the relationship, the parties have initially concluded in principal commercial agreements that expand the relationship with TerryWhite Chemmart and form a new relationship with each of HPS and Zest from EBOS’ Institutional Healthcare division. MedAdvisor estimates that over 3 years, these arrangements will generate ~$4m of revenue.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
7.9¢
Change
0.001(1.28%)
Mkt cap ! $49.35M
Open High Low Value Volume
7.7¢ 7.9¢ 7.6¢ $102.9K 1.330M

Buyers (Bids)

No. Vol. Price($)
1 200000 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 27812 1
View Market Depth
Last trade - 16.10pm 26/06/2025 (20 minute delay) ?
MDR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.